In 2015, Jiang L et al. reported that the LOX-1 immunohistochemical staining score combined with body mass index can predict the poor prognosis of patients with NSCLC and squamous cell carcinoma [21]. The gene discussed is OLR1; the disease is squamous cell carcinoma.